General Equipment
Size-exclusion chromatography was carried out on an ÄKTA FPLC system from GE Healthcare on a Superdex 75 10/300 column. Analytical RP-HPLC was performed on Agilent 1260 series instruments equipped with an Agilent TC-C18 column (5 µm, 4 .6 x 150 mm) at a flow rate of 1 mL/min. Electrospray ionization mass spectrometric analysis (ESI-MS) was performed on pAIE, pAIE precursors by direct infusion on a Bruker Dalton Amazon mass spectrometer. Coomassie blue or Silver stained gels were imaged on an EPSON PERFECTION V10 scanner. ELISA absorbance measurements at 450 nm were recorded on a BioRad micro plate reader. Western blot membranes and Dot blots were imaged using the GE Amersham Imager 600. All plasmids used in this study were sequenced by Sangon Biotech (Shanghai, China) to verify the correct DNA sequence. Cells were lysed using a Sonics & Materials (NewTown, CT) Sonifier. Samples were lyophilized on a CHRIST (Gemany) lyophilizer. High resolution mass spectra of organic compounds were recorded on a Bruker FT-MS. Nano-LC-MS/MS analyses were performed on high-mass-accuracy, reversed-phase Nano-UPLC-MS platforms， consisting of an Easy nLC Ultra 1000 nano-UPLC system (Thermo Fisher Scientific) coupled to a Q-Extractive Orbitrap mass spectrometer (Thermo Fisher Scientific, USA).
Supplementary Note 2
Computational Modeling of the Side-chains in pHis and pAIE Figure S1 . Computational modeling of the sidechains in ω-pArg (left) and pAIE (right). The optimum geometry and the electrostatic potential surface were obtained by DFT calculation (6-31* basis set) using the Spartan '10® package. 1 
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Synthesis of pAIE
General Synthetic Materials and Methods
All chemicals for the synthesis of pAIE were obtained from Sigma-Aldrich unless otherwise noted and used without further purification. All solvents were obtained from Sinopharm Chemical Reagent (Shanghai) unless otherwise noted. Silica gel (200-400 mesh) for flash column chromatograph (FCC) and glass-backed thin-layer chromatography (TLC) plates were purchased from Sinopharm Chemical Reagent. In a round bottom flask equipped with a magnetic stir bar, diethyl (cyanomethyl)phosphonate (5.30 g, 30.0 mmol) was dissolved in 25 mL toluene, followed by addition of tetrabutyl phosphonium bromide (Bu 4 P + Br -, 125 mg) and triethylamine (TEA, 6.05 g, 60.0 mmol). Dry hydrogen sulfide (H 2 S) was bubbled through the mixture for 5 h with stirring at 10 °C. The reaction mixture was stirred overnight at room temperature, followed by purged with dried nitrogen and then cooled at 4 °C for 1 hour. After filtration, the resultant yellow solid was repeatedly washed with toluene in the atmosphere of Argon to give the product as yellow solid (Compound 1) (2.37 g, 37% yield).
Dry hydrogen sulfide (H 2 S) was prepared according to the standard procedure. Briefly, ferrous sulfide (FeS) was reacted with hydrochloric acid (HCl) in a Kipp's S8 apparatus, and the generated H 2 S was dried by passing through solid phosphorus pentoxide (P 2 O 5 In a round bottom flask equipped with a magnetic stir bar, diethyl (2-amino-2-thioxoethyl) 
In a round bottom flask equipped with a magnetic stir bar, 2-(Diethylphosphono)-Smethylthioacetamidium Iodide (Compound 2) (611 mg, 1.73 mmol) and N-Bocethylenediamine (277 mg, 1.73 mmol) were dissolved in 3 mL methane and stirred for 3 h until TLC indicated the consumption of compound 2 at room temperature under Argon atmosphere. The reaction mixture was concentrated and the solvent was removed by rotary evaporation to give a white crude solid. The crude solid was washed with diethyl ether to give the pure product as a white solid (Compound 3) (628 mg, 78% yield). 
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Synthesis of (2-((2-ammonioethyl) 
In a round bottom flask equipped with a magnetic stir bar, 1-((2-((tertbutoxycarbonyl)amino)ethyl)amino)-2-(diethoxyphosphoryl)ethaniminium iodide (Compound 3) (370 mg, 0.80 mmol) was dissolved in 10 mL 33% HBr in acetic acid. The reaction mixture was then capped with a glass stopper and stirred at room temperature for 48-72 hours under Argon atmosphere until ESI-MS indicated complete loss of Boc-and ethyl protecting groups. The reaction process was further verified with 31 P NMR which indicated the consumption of Compound 3 and in which a new peak appeared in the upfield region. The reaction mixture was then concentrated to a solid by rotary evaporation. HBr was removed by freeze-drying and repeating addition and evaporation of methanol. Residual HBr was removed by repeating dissolvelyophilization cycle with ddH 2 O The crude solid was then dissolved in 2 mL of 0.1% AcOH and purified by cation exchange chromatography. This was done by loading the crude product onto 6 mL of strongly acidic cation exchange resin pre-equilibrated with 0.1% AcOH. The column was then washed with 12 mL 0.1% AcOH, followed by elution with 12 mL 500 mM ammonium acetate. All fractions including flow-through and eluent were collected in 1 mL fractions. Fractions containing product were identified by spotting on TLC plate and visualized with ninhydrin. Further verification was performed by ESI-MS if necessary. Fractions containing product were combined and then flash frozen in liquid nitrogen and lyophilized to dryness to give pAIE as a white solid (Compound 4, pAIE) (117 mg, 81% yield).
H NMR (500 MHz
Hz, 2H, -CNHCH 2 CH 2 ), 2.90 (dd, J = 20.0, 6.7 Hz, 2H, -CH 2 P) ppm. Conjugation of pAIE to KLH pAIE-KLH (5) was prepared employing glutaradehyde as a coupling reagent. Briefly, pAIE and keyhole limpet hemocyanin (KLH) were dissolved in coupling buffer (0.1 M Na 2 CO 3 , 0.15 M NaCl, pH 8.5) respectively and then mixed. The final concentration of pAIE is15 mM and that of KLH is 2 mg/mL. Glutaraldehyde (25% v/v) was slowly added to the mixture to get the final concentration of 0.5% (v/v). The mixture was incubated for two hours at RT, followed with the addition of solid NaBH 4 to a final concentration of 10 mg/mL and incubated for 2 hours at RT. Excessive and unreacted pAIE, Glutaraldehyde and NaBH 4 were removed by dialysis against PBS (pH 7.4) overnight. The concentration of protein was determined by Bradford method using BSA as a reference.
Conjugation of pArg and other phosphoamino acids to BSA pArg-BSA (6), pSer-BSA (12), pThr-BSA (13) and pTyr-BSA (14) were prepared employing glutaradehyde as a coupling reagent. Briefly, pAIE and keyhole limpet hemocyanin (KLH) were dissolved in coupling buffer (0.1 M Na 2 CO 3 , 0.15 M NaCl, pH 8.5) respectively and then mixed. The final concentration of pAIE is15 mM and that of KLH is 2 mg/mL. Glutaraldehyde (25% v/v) was slowly added to the mixture to get the final concentration of 0.5% (v/v). The mixture was incubated for two hours at RT, followed with the addition of solid NaBH 4 to a final concentration of 10 mg/mL and incubated for 2 hours at RT. Un-reacted pAIE, excessive glutaraldehyde and NaBH 4 were removed by dialysis against PBS (pH 7.4) overnight. The concentration of protein was determined by Bradford method using BSA as a reference.
Generation of Mouse Polyclonal pArg-Antibody
The mouse polyclonal antiserum was raised against pAIE-KLH (5). Four mice were subcutaneously injected with pAIE-KLH conjugate using a standard immunization protocol. Briefly, each mouse was injected with 200 μg pAIE-KLH conjugate per shot combined with equal volume of Fraud's complete adjuvant for primary immunization and with equal volume of Fraud's incomplete adjuvant for the subsequent injection. The interval time between two successive injections was around 2-3 weeks. The individual bleeds were screened for detection of the phosphor-arginine modification (pArg-BSA or Peptide 8) by ELISA using BSA or Peptide 7 as a control, respectively. All animal experiments were performed in keeping with AAALAC regulations and in accordance with animal ethical standards.
Buffers used in ELISA Protocol
Coating Buffer: 0.032 M Na 2 CO 3 , 0.068 M NaHCO 3 , pH 9.6 Wash Buffer: 10 mM Tris, pH 8.0, 150 mM NaCl, 0.05% v/v Tween 20
Pep 7 and pArg-Pep (8) in 1 mg/mL stock solutions were diluted 500-fold into coating buffer and 50 µL of each sample was added to a Nunc-Immuno Maxisorp 96-well plate to give 100 ng peptide/well. The plate was incubated for 2 hours at room temperature on a nutator. The wells were then washed three times with wash buffer. The wells were then blocked by adding 1% BSA in wash buffer at 200 µL/well and incubated for 1 hours at room temperature on a nutator. After removing blocking solution, mouse crude antiserum diluted in wash buffer at a indicated ratio was added to each well to give 100 µL/well and incubated for 45 minutes at room temperature on a nutator. The wells were then emptied and washed three times with wash buffer. Goat-anti rabbit-HRP secondary antibody was diluted 5000-fold into wash buffer and added to the wells at 50 µL/well and incubated for 45 minutes at room temperature on a nutator. The wells were emptied and washed four times with wash buffer. 100 µL of Ultra TMB ELISA substrate was added to each well and incubated for 15 minutes at room temperature followed by addition of 50 µL of 2 N H 2 SO 4 to quench the reaction. The absorbance at 450 nm was measured on a BioRad plate reader. 10 μL Protein A agarose resin was packed in a in-house made micro-column and washed with four 5 column volumes of TBS Equilibration buffer and then loaded with 50 μL 1:10 diluted mouse anti-serum in Equilibration buffer. The flow-through was collected, and the resin was washed with 25 μL TBS for 5 times. Antibodies were eluted from the column in 25 μL fractions with elution buffer. After elution off of the column, the elution fractions were immediately neutralized by adding 2.5 μL of 1 M Tris (pH8.0). Fractions containing pArg-Ab were determined by SDS-PAGE and ELISA.
SDS-PAGE of pArg-Ab Fractions 0.5 μL of the input and flow through fractions, and 0.5 μL of the wash and elution fractions were mixed 1:1 with 2× loading buffer (80 mM Tris pH 6.8, 20% v/v Glycerol, 2% SDS, 0.04% w/v Bromophenol Blue, 4% v/v 2-mercaptoethanol) and boiled at 95 °C for 5 min. The samples were loaded onto in-house made 12% Bis-Tris polyacrylamide gel and the proteins were resolved by electrophoresis by running at 180 V for 1 hour. The gel was stained by conventional Silver stain method and imaged on a GE Amersham Imager 600.
Expression and Purification of His 6 -tagged McsB
Plasmid Encoded McsB gene is a generous gift from Dr. Tim Clausen at Research Institute of Molecular Pathology, Austria 3 . The plasmid was transformed to E. coli BL21(DE3)-pLys strain. One picked up clone was grown in 5 mL LB media supplemented with Ampicillin (50 μg/mL) over night at 37 °C. 1 L media was inoculated with 5 mL overnight cultures and grown until the OD600 reached 0.8. The bacteria was induced by 0.5 mM IPTG at 18 °C, 200rpm for additional 12 h and then harvested by centrifugation (8000g, 10 min, 4 °C). Cell pellet was re-suspended in Lysis buffer containing 50 mM KH 2 PO 4 (pH 7.5), 500 mM KCl, 5% glycerol, 1 mM β-mercaptoethanol, 1 mM PMSF and pH 7.5 and disrupted by sonication. His 6 -McsB was purified using standard His-tag purification protocol according to manufacturer's recommendation, followed by SEC chromatograph on superdex G-75 column equilibrated with 20 mM Tris (pH8.0), 150 mM KCl. Purified His 6 -McsB was analyzed by SDS-PAGE and the concentration was determined with Bradford method.
Figure S15. SDS-PAGE analysis of purified His 6 -McsB
Sequence of His 6 -McsB DNA:
E R V E H H H H H H
Expression and Purification of His 6 -tagged CtsR
The DNA fragment encoded His 6 -CtsR was chemically synthesized and ligated into pET pET 21a by using NdeI and XhoI sites. The plasmid was transformed to E. coli BL21(DE3)-pLys strain. One picked up clone was grown in 5 mL LB media supplemented with Ampicillin (50 μg/mL) over night at 37 °C. 1 L media was inoculated with 5 mL overnight cultures and grown until the OD600 reached 0.8. The bacteria was induced by 0.5 mM IPTG at 37 °C, 250rpm for additional 2 h and then harvested by centrifugation (8000g, 10 min, 4 °C). Cell pellet was re-suspended in Lysis buffer containing 25 mM Tris (pH 8.0), 200 mM NaCl, 1 mM β-mercaptoethanol, 1 mM PMSF and disrupted by sonication. His 6 -CtsR was purified using standard His-tag purification protocol according to manufacturer's recommendation. Briefly, the lysate was cleared by centrifugation at 14000g for 10 min at 4 °C, and the supernatant was loaded onto the 1 mL Ni-NTA column pre-equilibrated with 25 mM Tris pH 8.0, 200 mM NaCl, 20 mM imidazole and then eluted according to a standard protocol. Fractions containing objective His 6 -CtsR were pooled. Excessive imidazole was removed by using Ultla Centrigugal Unit (Millipore, MWCO 3K), and the buffer was changed to500mM
KCl,15Mm KH 2 PO 4 , 2mM β-Mercaptoethanol Ph7.5. . Purified His 6 -CtsR was analyzed by SDS-PAGE and the concentration was determined with Bradford method.
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Figure S16. SDS-PAGE analysis of purified His 6 -CtsR
Sequence of His 6 -CtsR DNA: 
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In vitro Phosphorylation of Peptide 7 with McsB
Peptide 7 was enzymatically phosphorylated with recombinant protein arginine kinase McsB according to the literature with modification. 3 The kinase reaction was carried out in the presence of 40 μM Peptide 7, 15 μM McsB, 1mM ATP and 5mM MgCl 2 in 100 μL 20 mM Tris (pH8.0) at 30 °C for 1h. The sample was flash frozen and then stored at -80 °C or directly injected for LC separation. The product peak in LC chromatogram was identified by using coupled ESI-MS detector. When performing large-scale preparation, the sample could be freezing-dry first, to reduce injection volume. Preparation of pArg-Peptide 8
Peptide 8 was enzymatically synthesized from Peptide7 with protein arginine kinase McsB via in vitro kinase reaction. The reaction mixture was separated on Analytical RP-HPLC equipped with TC-C18 column (Agilent, 15cm4.6mm) at a flow rate of 1 mL/min. The elution was carried out employing gradients of solvent A (0.1% formic acid in water) and solvent B (95% acetonitrile in water with 0.1% formic acid). For preparation, a 27-minute linear gradient with increasing solvent B from 5% to 70% was adopted. All fractions containing the phosphorylated product were collected followed by neutralization to pH=8 with concentrated ammonia (25%). The organic solvent consisted of HPLC mobile phase was firstly removed by Speed-Vacuum at room temperature.
Residual water in the fractions, excessive ammonia and other volatile substances were further removed by freeze-drying. Purified Peptide 8 was finally stored frozen at -80 ºC for further use. Peptide 8 could also be re-dissolved in PBS, and quantified by measuring its UV absorption at 275 nm with Nano-drop (Thermal Scientific) using Peptide 7 stock solution as reference. 
Nano-LC-MS analysis of Peptide 8
For Nano-LC-MS/MS analyses, 100 ng purified peptide 8 was separated on nanoC18 column (Acclaim, 15 cm x 50 μm x 2 μm, Dionex) at a flow of 350nL/min, under a linear gradient of A and B solution with increasing solvent B from 8%-35% over 30min (solvent A: water with 0.1% formic acid；solvent B: 95% acetonitrile with 0.1% formic acid).
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Alternatively, direct infusion with a sprayer tip was used. Full-scan mass spectra were acquired in positive-ion mode over the m/z range of 350-1800 at a resolution of 70,000. MS/MS spectra were simultaneously acquired using HCD for the 20 most abundant multiply charged species in the full-scan spectrum having signal intensities of > 1000. For protein identification experiments, dynamic exclusion was set such that MS/MS was acquired only once for each species over a period of 60 s. All spectra were acquired in profile mode.
In vitro Phosphorylation of CtsR
CtsR was phosphorylated with recombinant protein arginine kinase McsB according to the literature with modification 3 . The kinase reaction was carried out in the presence of 10 μM purified CtsR, 5 μM McsB, 1mM ATP and 5mM MgCl 2 in 100 μL 20 mM Tris (pH8.0) at 30 °C for 1h. The reaction was quenched with equal volume of 4 ×Basic Loading Buffer and stored at -80 °C for further use.
Nano-LC-MS analysis of phosphorylated CtsR
After in vitro phosphorylation, the McsB/CtsR reaction mixture was 5-fold diluted with 50 mM NH 4 HCO 3 , reducing the concentration of CtsR to 2 μM CtsR. The mixture was treated with 25 mM DTT for 30 minutes at RT and then 50 mM iodoacetamide for 30 minutes in dark, followed by addition of DTT to the concentration of 100 mM and incubation at RT for another 30 minutes in dark. Excessive DTT and iodoacetamide were removed by using Ultra Centrifigual Unit (Millipore, MWCO 3K) and the buffer was changed to 50 mM NH 4 HCO 3 . Trypsin digestion was perform at 37 °C for 8 hours with a ratio of 100:1 (by weight, protein : trypsin) and the final concentration of protein was 0.1 mg/mL. Resulted enzymatic hydrolysate was freezing-dry for further analysis.
For Nano-LC-MS/MS analyses, 1 μg enzymatic hydrolysate were separated on nanoC18 column (Acclaim, 15 cm x 50 μm x 2 μm, Dionex) at a flow of 350nL/min, under a linear gradient of A and B solution with increasing solvent B from 8%-35% over 30min (solvent A: water with 0.1% formic acid；solvent B: 95% acetonitrile with 0.1% formic acid). Full-scan mass spectra were acquired in positive-ion mode over the m/z range of 350-1800 at a resolution of 70,000. MS/MS spectra were simultaneously acquired using HCD for the 10 most abundant multiply charged species in the full-scan spectrum having signal intensities of > 1000. For protein identification experiments, dynamic exclusion was set such that MS/MS was acquired only once for each species over a period of 60 s. All spectra were acquired in profile mode. 
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Supplementary Note 6
General Notes for Assays with anti-pArg antibody Purified pArg-Ab and anti-serum were stored at 4 °C for at least three months without any detected loss in binding affinity. Tris buffered saline pH 8.0 was used in all pArg antibody assays. A basic gel-loading buffer with a pH of 8.5 was selected for WB and SDS-PAGE and we did NOT boil the samples after mixing with loading buffer prior to loading them onto the gel. Tris-HCl gels were preferred over Bis-Tris gels due to its more basic running buffer (pH 8.3 vs. pH 7.3) according to literatures 4 . 3% BSA but not conventional skim milk was selected as a blocking agent in ELISAs and Western Blots due to the possible casein contamination in skim milk.
Comparison on the Coating Efficiency of Peptide 7 and 8
In view of the possible problem in ELISA using short peptides as antigen, a preexperiment was conducted to determine the coating efficiency of Peptide 7 and 8 (~1.5 kDa), a pair of positive and negative control used in ELISA for evaluation of anti-pArg serum. Briefly, Peptide 7 or Peptide 8 in 1 mM stock solutions were diluted 1000-fold into coating buffer, and 1 mL of each sample was added to an INNOVAX 96-well plate to give 50 µL/well. The plate was incubated for 2 hours at RT on a nutator, and the coating solution of each peptide was recovered from each well, pooled and lyophilized. The residues were re-dissolved in 20 µL ddH 2 O, and quantified by measuring its UVabsorption at 275 nm relative to 1 mL Peptide solution or 1 mL Coating buffer processed with the same procedures except for "coating step". The coating efficiency of Pep 7 and Pep 8 were 88.3 % vs. 86.5 % (3 individual experiment), which is comparable without obvious difference. Peptide 7 and Peptide 8 in 1 mM stock solutions or BSA, pArg-BSA were diluted into coating buffer to give the concentration of 1 μM and 2 μg/mL for peptide and protein samples, respectively. The ELISA was then carried out in an analogous manner to the procedure described above. Briefly, after adding the coating samples, the plate was incubated for 2 hours at RT and then washed with wash buffer. The wells were then blocked with 200 μL 1 % BSA in wash buffer. The blocking solution was then removed from each well and a serial of 10-fold diluted crude mouse anti-pArg antiserum or 1:100 diluted Protein A purified antibody in wash buffer was added to the wells and incubated for 45 mins at RT. The wells were then washed with wash buffer for 3 times. Goat-anti mouse HRP secondary antibody diluted 5000-fold into wash buffer was the added to the wells and incubated for 45 mins at RT. The wells were washed with wash buffer and treated with 100 μL Ultra TMB ELISA substrate. 50 μL 2 N H 2 SO 4 was then added to each well and the absorbance at 450 nm was measured on a Bio-Rad plate reader. Figure S21 . Detection of polyclonal pArg-Ab subtype in mouse serum. The ELISA plate was coated with peptide 8 as a capture antibody and peptide 7 was used as a control for background deduction
General Procedure for Dot Blot Assay
Peptides 7-11 were diluted to a final concentration of 500 µM in ddH 2 O buffer and further serially diluted three-fold with ddH 2 O in a siliconized Eppendorf tube. 0.2 µL of each solution was spotted onto nitrocellulose membrane and the membrane was air dried followed by blocking with 3% BSA in TBST (10 mM Tris, pH 8.0, 150 mM NaCl,
